Our Partners > Platinum Sponsors 2019



 PLATINUM SPONSORS

AbbVie, a global, researched-based biopharmaceutical company, is committed to educating patients and caregivers about Parkinson’s disease to raise awareness about the condition, and further research to improve the lives of those living with and impacted by this disease. AbbVie is a proud sponsor of the Parkinson’s Unity Walk. For further information on the company and its people, portfolio and commitments, please visit www.abbvie.com.

 



Acorda is proud to support the Parkinson’s Unity Walk, and we are excited to join people with Parkinson’s, their family and friends in April to raise awareness of Parkinson’s. As an emerging leader in Parkinson’s, our goal is to support the Parkinson’s community through medical research, educational initiatives and programs like the Unity Walk that help people with Parkinson’s.

Founded in 1995, Acorda is focused on developing therapies to restore neurological function. We also have a strong commitment to the communities we serve through our extensive outreach programs and advocacy support, providing information and resources to help people with neurological disorders.

In addition, at this year’s Unity Walk, we are hosting the fifth annual “I Walk Because…” t-shirt booth. “I Walk Because…” is one of Acorda’s first community programs and gives a voice to individuals to celebrate their strength, support and resiliency. Stop by our booth and tell us why you’re walking this year! To learn more about Acorda, please visit www.acorda.com.

 

Challenging Convention, Changing Lives

The Amneal team brings people and passion together to support our mission of making healthy possible for individuals affected by conditions like Parkinson’s disease. We believe every idea, every experience, and every detail can make a difference. That’s why we connect our passionate people to partnerships with patients, care partners, healthcare providers, and advocacy organizations.

We believe we can make a difference in the Parkinson’s community not just by bringing medicines to market, but by actively engaging with patients and care partners to understand the journey, unmet needs, opportunities to provide support—and to ensure their voice is reflected in everything we do.

Amneal also supports leading patient advocacy organizations across the U.S., including The Michael J. Fox Foundation for Parkinson's Research, Parkinson’s Foundation, PMD Alliance, American Parkinson Disease Association, and The Parkinson Alliance. We provide valuable resources that help raise awareness and funding for important education and research.

We are Amneal. And we’re making healthy possible for Parkinson’s patients.

 

Boston Scientific is a proud sponsor of the 2019 Parkinson’s Unity Walk. Our FDA-approved therapy for patients with Parkinson’s disease is backed by rigorous clinical data and the experiences of our patients around the world. To learn more about DBS from Boston Scientific, and to hear from our patients in their own words, visit DBSandMe.com.
 
Founded in 1979, Boston Scientific is dedicated to transforming the lives of patients around the world. Each year, our devices treat 22 million patients in over 100 countries. Throughout our history, we've collaborated with healthcare providers to create meaningful solutions that matter to clinicians and patients. Our unwavering commitment to excellence shows up in our product development, manufacturing rigor, and education of clinicians and patients—and ultimately in the devices that go to the patients we serve.

 

As a company committed to “taking the walk of life, one life at a time,” Kyowa Kirin International, PLC is proud to support the Parkinson’s Unity Walk. We are a global research-based life sciences company specializing in biotechnologies with over 8,000 employees. Our core therapeutic areas are oncology, neuroscience, nephrology, and immunology and allergy. The company leverages leading-edge technologies to improve the health and well-being of people worldwide.

 

 

LSVT Global has researched and developed highly effective speech, physical and occupational therapy programs (LSVT LOUD and LSVT BIG) for people with Parkinson's disease.  Visit our website to find LSVT Certified Clinicians near you, exercise videos for improving voice and movements, free online and live educational events, and a speech exercise software program.  LSVT Global has trained over 30,000 clinicians from 73 countries. LSVT LOUD is the gold standard in speech treatment for people with PD, backed by 20+ years of funded research from the National Institutes of Health. LSVT LOUD can now be received in person or via telehealth (eLOUD) or by using our LSVT Companion speech exercise program.   The LSVT BIG physical/occupational therapy program empowers people with PD to improve their movement and balance for greater confidence at work, home, and play. During the Unity Walk, meet LSVT LOUD and LSVT BIG experts at our booth and learn more about how you can keep your voice and movements alive with LSVT!  For more information, visit www.LSVTGlobal.com.  

 

Deep brain stimulation (DBS) development started in 1987 and Medtronic has been the leader in the field ever since, with over 150,000 implanted with Medtronic DBS Therapy. The Medtronic DBS Therapy system has been rigorously tested with clinical evidence and is FDA approved for people with Parkinson’s who had recent onset of movement symptoms as well as those with longer-standing movement symptoms. To learn more about Medtronic DBS Therapy, please visit www.MedtronicDBS.com.

As a global leader in medical technology, services and solutions, Medtronic strives to improve the health and lives of millions of people each year. We believe our deep clinical, therapeutic and economic expertise can help address the complex challenges — such as rising costs, aging populations and the burden of chronic disease — faced by families and healthcare systems today. But no one can do it alone. That’s why we’re committed to partnering in new ways and developing powerful solutions that deliver better patient outcomes. Join us in our commitment to take healthcare Further, Together.


Vertical Pharmaceuticals, LLC is an indirect subsidiary of Osmotica Pharmaceuticals PLC. Vertical Pharmaceuticals is dedicated to the therapeutic areas of neurology and women’s health.

Osmotica Pharmaceuticals, the parent company of Vertical Pharmaceuticals is a publicly held, fully-integrated biopharmaceutical company focused on developing, manufacturing and commercializing specialty products.  Osmotica Pharmaceuticals is headquartered in Bridgewater, NJ.


Voyager Therapeutics is a clinical-stage gene therapy company focused on developing life-changing treatments for severe neurological diseases. Voyager is committed to advancing the field of AAV gene therapy through innovation and investment in vector engineering and optimization, manufacturing and dosing and delivery techniques. Voyager’s pipeline focuses on severe neurological diseases in need of effective new therapies, including Parkinson’s disease, a monogenic form of ALS called SOD1, Huntington’s disease, Friedreich’s ataxia, neurodegenerative diseases related to defective or excess aggregation of tau protein in the brain including Alzheimer’s disease and severe, chronic pain.  We recently dosed the first patient in the RESTORE-1, Phase 2 trial in patients with Parkinson’s disease. For additional information regarding this trial with our gene therapy VY-AADC for the treatment of Parkinson’s disease, please use the following link or email Voyager at clinicaltrials@vygr.com.

 

 

Click for a printer friendly version

Back